Back
Biolase 10K Form
Sell
43
BIOL
Biolase
Last Price:
0.16
Seasonality Move:
2.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIOL News And Ratings
See the #1 stock for the next 7 days that we like better than BIOL
BIOL Financial Statistics
Sales & Book Value
| Annual Sales: | $49.16M |
|---|---|
| Cash Flow: | $-5.94M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.06 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -19.71200 |
|---|---|
| Net Income (TTM): | $-21.27M |
| Gross Margin: | $16.72M |
| Return on Equity: | -450.44% |
| Return on Assets: | -56.04% |
Biolase Earnings Forecast
Key Biolase Financial Ratios
- The Gross Profit Margin over the past 32 years for BIOL is 34.02%.
- The Selling, General & Administrative Expenses for BIOL have been equal to 58.29% of Gross Profit Margin.
- The Research & Development expenses have been 12.21% of Revenue.
- The Interest Expense is -11.44% of Operating Income.
- The Net Earning history of BIOL is -41.97% of Total Revenues.
- Per Share Earnings over the last 32 years have been positive in 20 years.
Biolase Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | BIOL |
| CUSIP: | 090911 |
| Website: | biolase.com |
Debt
| Debt-to-Equity Ratio: | 52.07 |
|---|---|
| Current Ratio: | 1.17 |
| Quick Ratio: | 0.56 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 5.3 |